Ibrutinib is a small molecule kinase inhibitor used to treat several B-cell malignancies, including chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström's macroglobulinemia, as well as chronic… Read more
![Chemical structure of 1-((S)-3-(5-(3-((R)-3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-oxopropyl)-4-imino-3-(4-phenoxyphenyl)-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-S-3-5-3-R-3-4-Amino-3-4-phenoxyphenyl-1H-pyrazolo34-dpyrimidin-1-ylpiperidin-1-yl-3-oxopropyl-4-imino-3-4-phenoxyphenyl-45-dihydro-1H-pyrazolo34-dpy.png&w=3840&q=75)
![Chemical structure of 1-(1-Nitrosopiperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2256059-43-3-1-1-Nitrosopiperidin-3-yl-3-4-phenoxyphenyl-1H-pyrazolo34-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2142634-18-0-1-4-4-Amino-3-4-2-morpholinoethoxyphenyl-1H-pyrazolo34-dpyrimidin-1-ylphenyl-3-5-tert-butylisoxazol-3-ylurea.png&w=3840&q=75)
![Chemical structure of 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidyl]-3-[[(1R)-3-(4-phenoxyphenyl)-1-(1-prop-2-enoyl-3-piperidyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]propan-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2031255-23-7-1-3R-3-4-Amino-3-4-phenoxyphenylpyrazolo34-dpyrimidin-1-yl-1-piperidyl-3-1R-3-4-phenoxyphenyl-1-1-prop-2-enoyl-3-piperidylpyrazolo34-dpyr.png&w=3840&q=75)
![Chemical structure of 1-[4-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F936563-92-7-1-4-4-Amino-3-4-phenoxyphenyl-1H-pyrazolo34-dpyrimidin-1-yl-1-piperidinyl-2-propen-1-one.png&w=3840&q=75)
![Chemical structure of 1-Butyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2213398-77-5-1-Butyl-3-4-phenoxyphenyl-1H-pyrazolo34-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of 1-Ethyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2213398-76-4-1-Ethyl-3-4-phenoxyphenyl-1H-pyrazolo34-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of 1-Isopropyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2803461-05-2-1-Isopropyl-3-4-phenoxyphenyl-1H-pyrazolo34-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of 1-Methyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2213398-75-3-1-Methyl-3-4-phenoxyphenyl-1H-pyrazolo34-dpyrimidin-4-amine.png&w=3840&q=75)




![Chemical structure of 2-Methyl-3-(4-phenoxyphenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-Methyl-3-4-phenoxyphenyl-2H-pyrazolo34-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of 3,3'-(Oxybis(4,1-phenylene))bis(1H-pyrazolo[3,4-d]pyrimidin-4-amine)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F33-Oxybis41-phenylenebis1H-pyrazolo34-dpyrimidin-4-amine.png&w=3840&q=75)

![Chemical structure of 3-((S)-2-(4-Amino-3-(4-(cyclohexa-1,3-dien-1-yloxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-1-((S)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-S-2-4-Amino-3-4-cyclohexa-13-dien-1-yloxyphenyl-1H-pyrazolo34-dpyrimidin-1-ylpiperidin-1-yl-1-S-3-4-amino-3-4-phenoxyphenyl-1H-pyrazolo34-dpyrimidin.png&w=3840&q=75)
![Chemical structure of 3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1412418-47-3-3-4-Phenoxyphenyl-1-piperidin-3-yl-1H-pyrazolo34-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F330786-24-8-3-4-Phenoxyphenyl-1H-pyrazolo34-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-4-Phenoxyphenyl-1H-pyrazolo34-dpyrimidin-4-ol.png&w=3840&q=75)

![Chemical structure of 3-Bromo-1H-pyrazolo[3,4-d]pyrimidin-4-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-Bromo-1H-pyrazolo34-dpyrimidin-4-ol.png&w=3840&q=75)
![Chemical structure of 3-Bromo-4-((tert-butyldimethylsilyl)oxy)-1H-pyrazolo[3,4-d]pyrimidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-Bromo-4-tert-butyldimethylsilyloxy-1H-pyrazolo34-dpyrimidine.png&w=3840&q=75)
![Chemical structure of 3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F151266-23-8-3-Iodo-1H-pyrazolo34-dpyrimidin-4-amine.png&w=3840&q=75)

![Chemical structure of 4-Aminopyrazolo[3,4-d]pyrimidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2380-63-4-4-Aminopyrazolo34-dpyrimidine.png&w=3840&q=75)





![Chemical structure of 6-(3-Amino-5-(4-phenoxyphenyl)-1-((R)-piperidin-3-yl)-1H-pyrazol-4-yl)-3-(4-phenoxyphenyl)-1-((R)-piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6-3-Amino-5-4-phenoxyphenyl-1-R-piperidin-3-yl-1H-pyrazol-4-yl-3-4-phenoxyphenyl-1-R-piperidin-3-yl-1H-pyrazolo34-dpyrimidin-4-amine.png&w=3840&q=75)
![Chemical structure of 6-(3-Amino-5-(4-phenoxyphenyl)-1H-pyrazol-4-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6-3-Amino-5-4-phenoxyphenyl-1H-pyrazol-4-yl-3-4-phenoxyphenyl-1H-pyrazolo34-dpyrimidin-4-amine.png&w=3840&q=75)

![Chemical structure of Ethyl (R)-3-(1-(1-acryloylpiperidin-3-yl)-4-imino-3-(4-phenoxyphenyl)-1,4-dihydro-5H-pyrazolo[3,4-d]pyrimidin-5-yl)propanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FEthyl-R-3-1-1-acryloylpiperidin-3-yl-4-imino-3-4-phenoxyphenyl-14-dihydro-5H-pyrazolo34-dpyrimidin-5-ylpropanoate.png&w=3840&q=75)
![Chemical structure of Ethyl (R)-3-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FEthyl-R-3-3-4-amino-3-4-phenoxyphenyl-1H-pyrazolo34-dpyrimidin-1-ylpiperidin-1-ylpropanoate.png&w=3840&q=75)












Ibrutinib is a small molecule kinase inhibitor used to treat several B-cell malignancies, including chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström's macroglobulinemia, as well as chronic graft-versus-host disease. As a Bruton’s tyrosine kinase (BTK) inhibitor, it functions by forming a covalent bond with the enzyme to disrupt B-cell receptor signaling pathways. To support pharmaceutical quality control and research, this category provides a comprehensive range of reference standards, including Ibrutinib API, its synthetic intermediates, degradation products, and structural analogs. Laboratories utilize these high-quality materials for impurity profiling, method validation, and routine analytical testing to ensure regulatory compliance. Additionally, stable isotope labelled compounds are available to serve as internal standards in mass spectrometry workflows, facilitating precise quantification and accurate identification of metabolites and impurities throughout the drug development lifecycle.